Literature DB >> 4016042

Medical conditions underlying recurrence of retinal vein occlusion.

P M Dodson, A J Kubicki, K G Taylor, E E Kritzinger.   

Abstract

Seventeen patients with recurrent retinal vein occlusion were investigated for underlying medical conditions and compared with 61 patients with single retinal vein occlusion (26 with central, 35 with branch vein occlusion). The two study groups were comparable for age, sex, and weight. Patients with recurrence had a significantly increased prevalence rate of hypertension (88% versus 48%: p less than 0.01), with a trend to increased hyperlipidaemia (47% versus 33%) compared with patients with a single episode. A significantly raised mean systolic (p less than 0.05) but not diastolic blood pressure was found in patients with recurrence. Other cardiovascular risk factors in patients with recurrence were also found and included lower mean levels of high density lipoprotein (HDL)-cholesterol (p less than 0.02) and the HDL2 subfraction (p less than 0.001), and a significantly increased proportion of patients with regular alcohol intake (p less than 0.01). We conclude that hypertension and hyperlipidaemia with an increase in other cardiovascular risk factors are commonly found in patients with recurrent retinal vein occlusion and may therefore be important aetiological factors. The possible benefits of treatment of these underlying conditions to prevent recurrence need to be assessed in well designed prospective studies.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4016042      PMCID: PMC1040653          DOI: 10.1136/bjo.69.7.493

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  14 in total

1.  Retinal vein occlusion: long-term prospects: 10 years' follow-up of 143 patients.

Authors:  K Rubinstein; E B Jones
Journal:  Br J Ophthalmol       Date:  1976-02       Impact factor: 4.638

2.  A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol.

Authors:  G R Warnick; J J Albers
Journal:  J Lipid Res       Date:  1978-01       Impact factor: 5.922

3.  Do medical conditions have an influence on central retinal vein occlusions?

Authors:  E M Kohner; J M Cappin
Journal:  Proc R Soc Med       Date:  1974-10

4.  Haemostatic studies on retinal vein occlusion. Fibrinolytic response to venostasis as a prognostic factor for spontaneous recanalization.

Authors:  M Peduzzi; V De Rosa; S Fonda; S Coccheri
Journal:  Thromb Res       Date:  1981 Oct 1-15       Impact factor: 3.944

Review 5.  Epidemiology of hypertension: blood pressure in blacks and whites.

Authors:  J K Cruickshank; D G Beevers
Journal:  Clin Sci (Lond)       Date:  1982-01       Impact factor: 6.124

6.  Retinal vein occlusion and the prevalence of lipoprotein abnormalities.

Authors:  P M Dodson; D J Galton; A M Hamilton; R K Blach
Journal:  Br J Ophthalmol       Date:  1982-03       Impact factor: 4.638

7.  The management of central retinal vein occlusion.

Authors:  E M Kohner; L Laatikainen; J Oughton
Journal:  Ophthalmology       Date:  1983-05       Impact factor: 12.079

8.  Retinal vascular abnormalities in the hyperlipidaemias.

Authors:  P M Dodson; D J Galton; A F Winder
Journal:  Trans Ophthalmol Soc U K       Date:  1981

9.  beta-thromboglobulin and platelet factor 4 levels in retinal vein occlusion.

Authors:  P M Dodson; J Westwick; G Marks; V V Kakkar; D J Galton
Journal:  Br J Ophthalmol       Date:  1983-03       Impact factor: 4.638

10.  Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins.

Authors:  N E Miller; F Hammett; S Saltissi; S Rao; H van Zeller; J Coltart; B Lewis
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-30
View more
  7 in total

Review 1.  Central retinal vein occlusion: what's the story?

Authors:  T H Williamson
Journal:  Br J Ophthalmol       Date:  1997-08       Impact factor: 4.638

Review 2.  Management of retinal vein occlusion.

Authors:  P M Dodson; E E Kritzinger
Journal:  Br Med J (Clin Res Ed)       Date:  1987-12-05

3.  Medical conditions underlying retinal vein occlusion in patients with glaucoma or ocular hypertension.

Authors:  M D Cole; P M Dodson; S Hendeles
Journal:  Br J Ophthalmol       Date:  1989-09       Impact factor: 4.638

4.  Antithrombotic treatment of retinal vein occlusion: a position statement from the Italian Society on Thrombosis and Haemostasis (SISET).

Authors:  Francesco Paciullo; Emanuele Valeriani; Angelo Porfidia; Marcello Di Nisio; Marco P Donadini; Rossella Marcucci; Domenico Prisco; Carlo Cagini; Paolo Gresele; Walter Ageno
Journal:  Blood Transfus       Date:  2022-01-21       Impact factor: 5.752

5.  Central retinal vein occlusion in a young Chinese population: risk factors and associated morbidity and mortality.

Authors:  Jane Zea-Chin Kuo; Chi-Chun Lai; Frank Shih-Chang Ong; Chia-Pang Shih; Ling Yeung; Tun-Lu Chen; Kuan-Jen Chen; Wei-Chi Wu
Journal:  Retina       Date:  2010-03       Impact factor: 4.256

6.  Cardiovascular risk factors and outcome in patients with retinal vein occlusion.

Authors:  Mirko Di Capua; Antonio Coppola; Rosina Albisinni; Antonella Tufano; Anna Guida; Matteo Nicola Dario Di Minno; Ferdinando Cirillo; Marcello Loffredo; Anna Maria Cerbone
Journal:  J Thromb Thrombolysis       Date:  2010-07       Impact factor: 2.300

7.  Homocysteine, MTHFR C677T gene polymorphism, folic acid and vitamin B 12 in patients with retinal vein occlusion.

Authors:  Paola Ferrazzi; Pierpaolo Di Micco; Ilaria Quaglia; Lisa Simona Rossi; Alessandro Giacco Bellatorre; Giorgio Gaspari; Lidia Luciana Rota; Corrado Lodigiani
Journal:  Thromb J       Date:  2005-09-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.